Great Lakes Advisors LLC purchased a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) in the second quarter, Holdings Channel reports. The firm purchased 18,810 shares of the company’s stock, valued at approximately $788,000.
Other hedge funds have also bought and sold shares of the company. Handelsbanken Fonder AB purchased a new position in Guardian Pharmacy Services in the second quarter worth $511,000. Bank of America Corp DE grew its stake in Guardian Pharmacy Services by 86.1% in the 1st quarter. Bank of America Corp DE now owns 128,048 shares of the company’s stock valued at $4,822,000 after purchasing an additional 59,245 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Guardian Pharmacy Services by 67.4% during the 1st quarter. The Manufacturers Life Insurance Company now owns 11,820 shares of the company’s stock valued at $445,000 after purchasing an additional 4,761 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Guardian Pharmacy Services by 79.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 38,185 shares of the company’s stock valued at $1,438,000 after purchasing an additional 16,866 shares during the last quarter. Finally, Sei Investments Co. raised its stake in shares of Guardian Pharmacy Services by 40.5% during the 1st quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock worth $13,489,000 after purchasing an additional 103,177 shares during the period.
Analyst Upgrades and Downgrades
GRDN has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday. Zacks Research downgraded shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Bank of America lifted their price objective on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Finally, Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Guardian Pharmacy Services has an average rating of “Moderate Buy” and a consensus target price of $43.83.
Guardian Pharmacy Services Price Performance
Guardian Pharmacy Services stock opened at $37.90 on Friday. The firm has a market capitalization of $1.89 billion, a P/E ratio of 36.80, a PEG ratio of 1.96 and a beta of 0.10. Guardian Pharmacy Services, Inc. has a one year low of $23.14 and a one year high of $47.02. The business has a fifty day moving average price of $40.44 and a 200-day moving average price of $37.71.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The company had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. Sell-side analysts expect that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current fiscal year.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
